GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tikun Olam Cannbit Pharmaceuticals Ltd (XTAE:TKUN) » Definitions » EBITDA Margin %

Tikun Olam Cannbit Pharmaceuticals (XTAE:TKUN) EBITDA Margin % : -59.15% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Tikun Olam Cannbit Pharmaceuticals EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tikun Olam Cannbit Pharmaceuticals's EBITDA for the six months ended in Dec. 2023 was ₪-12.83 Mil. Tikun Olam Cannbit Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was ₪21.70 Mil. Therefore, Tikun Olam Cannbit Pharmaceuticals's EBITDA margin for the quarter that ended in Dec. 2023 was -59.15%.


Tikun Olam Cannbit Pharmaceuticals EBITDA Margin % Historical Data

The historical data trend for Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tikun Olam Cannbit Pharmaceuticals EBITDA Margin % Chart

Tikun Olam Cannbit Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -91.87 -35.23 9.80

Tikun Olam Cannbit Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.47 2.32 15.42 -89.41 -59.15

Competitive Comparison of Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin % falls into.



Tikun Olam Cannbit Pharmaceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=4.831/49.297
=9.80 %

Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-12.833/21.695
=-59.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tikun Olam Cannbit Pharmaceuticals  (XTAE:TKUN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Tikun Olam Cannbit Pharmaceuticals EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Tikun Olam Cannbit Pharmaceuticals's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tikun Olam Cannbit Pharmaceuticals (XTAE:TKUN) Business Description

Traded in Other Exchanges
N/A
Address
The Fourteenth, Tel Aviv, ISR
Tikun Olam Cannbit Pharmaceuticals Ltd is engaged in the business of growing and marketing medical cannabis.

Tikun Olam Cannbit Pharmaceuticals (XTAE:TKUN) Headlines

No Headlines